Melis N. Anahtar, Jacqueline A. Valeri, Seyed Majed Modaresi, Aarti Krishnan, Nina M. Donghia, Saman / science - Science Translational Medicine, Volume 18, Issue 854, June 2026.
AI Summary: Researchers used deep‑learning screening of millions of compounds to identify two promising leads active against drug‑resistant Neisseria gonorrhoeae. The AI‑driven approach accelerated hit discovery and produced chemical scaffolds now entering preclinical follow‑up, offering a potential new avenue in an area desperate for novel antibiotics.
UK begins human testing of first AI-designed 'universal' vaccine / 13 days
Engineered 15‑strain biotherapeutic matches donor FMT for C. difficile / 14 days
One hepatitis B drug shows early functional cures in trial / 21 days
Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 5 wks
Moderna reaches multibillion-dollar settlement over mRNA patents / 3 months
Favipiravir shows promise in Lassa fever Phase 2 trial / 5 wks
Therapeutic HPV vaccine slows throat tumors in preclinical tests / 4 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.